# WuXi Biologics (Cayman) Inc. (WXIBF)

> 医疗保健 · CN · 以 CNY 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/WXIBF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 21.59B | ¥ 4.87B | ¥ 2.70B | ¥ 3.11B | ¥ 47.27B |
| 2024 | ¥ 18.77B | ¥ 3.37B | ¥ 1.29B | ¥ 4.94B | ¥ 41.82B |
| 2023 | ¥ 17.13B | ¥ 3.42B | ¥ 439.74M | ¥ 4.56B | ¥ 40.33B |
| 2022 | ¥ 15.31B | ¥ 4.43B | ¥ -327.66M | ¥ 4.42B | ¥ 35.05B |
| 2021 | ¥ 10.50B | ¥ 3.46B | ¥ -3.14B | ¥ 4.30B | ¥ 32.28B |
| 2020 | ¥ 5.81B | ¥ 1.75B | ¥ -4.29B | ¥ 3.33B | ¥ 20.56B |
| 2019 | ¥ 4.14B | ¥ 1.05B | ¥ -2.08B | ¥ 2.19B | ¥ 12.78B |
| 2018 | ¥ 2.75B | ¥ 683.58M | ¥ -627.63M | ¥ 0 | ¥ 7.99B |
| 2017 | ¥ 1.79B | ¥ 279.10M | ¥ -342.84M | ¥ 0 | ¥ 4.02B |
| 2016 | ¥ 790.59M | ¥ 99.82M | ¥ -354.36M | ¥ 1.13B | ¥ 270.47M |
| 2015 | ¥ 799.08M | ¥ 63.85M | ¥ -325.94M | ¥ 455.86M | ¥ 146.00M |
| 2014 | ¥ 290.24M | ¥ 36.71M | ¥ -25.84M | ¥ 55.41M | ¥ 371.83M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.07 |
| 总负债 / 股东权益 | 0.23 |
| 流动比率 | 3.14 |

## 债务覆盖

| 指标 | 数值 |
| --- | --- |
| 总债务 / 盈利 | 1.33 |

## 其他视图

- [指标](https://sponda.capital/zh/WXIBF.md)
- [图表](https://sponda.capital/zh/WXIBF/charts.md)
- [对比](https://sponda.capital/zh/WXIBF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-23。